Salivary hypofunction: An update on aetiology, diagnosis and therapeutics

Archives of Oral Biology

Volumn 60, Issue 2, 2015, Pages 242-255

  Saleh, Jamil ^a   Figueiredo, Maria Antonia Zancanaro ^a   Cherubini, Karen ^a   Salum, Fernanda Gonçalves ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Medications; Radiotherapy; Salivary glands; Therapeutics; Xerostomia

Indexed keywords

HUMAN; PATHOPHYSIOLOGY; RISK FACTOR; XEROSTOMIA;

HUMANS; RISK FACTORS; XEROSTOMIA;

EID: 84911124675     PISSN: 00039969     EISSN: 18791506     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2014.10.004     Document Type: Review

References (200)

1. L.C. Schenkels, E.C. Veerman, and A.V. Nieuw Amerongen Biochemical composition of human saliva in relation to other mucosal fluids Crit Rev Oral Biol Med 6 2 1995 161 175
2. A.V. Amerongen, and E.C. Veerman Saliva - the defender of the oral cavity Oral Dis 8 1 2002 12 22
3. N.M. Farsi Signs of oral dryness in relation to salivary flow rate, pH, buffering capacity and dry mouth complaints BMC Oral Health 7 2007 15
4. M.W. Dodds, D.A. Johnson, and C.K. Yeh Health benefits of saliva: a review J Dent 33 3 2005 223 233
5. H. Mese, and R. Matsuo Salivary secretion, taste and hyposalivation J Oral Rehabil 34 10 2007 711 723
6. W.R. Thelin, M.T. Brennan, P.B. Lockhart, M.L. Singh, P.C. Fox, and A.S. Papas The oral mucosa as a therapeutic target for xerostomia Oral Dis 14 8 2008 683 689
7. T. Dijkema, C.P. Raaijmakers, P.M. Braam, J.M. Roesink, E.M. Monninkhof, and C.H. Terhaard Xerostomia: a day and night difference Radiother Oncol 104 2 2012 219 223
8. T. Nederfors Xerostomia and hyposalivation Adv Dent Res 14 2000 48 56
9. C. Scully, and D.H. Felix Oral medicine - update for the dental practitioner: dry mouth and disorders of salivation Br Dent J 199 7 2005 423 427
10. S.R. Porter Xerostomia: prevalence, assessment, differential diagnosis and implications for quality of life Oral Dis 16 6 2010 501 502
11. C.D. Löfgren, C. Wickström, M. Sonesson, P.T. Lagunas, and C. Christersson A systematic review of methods to diagnose oral dryness and salivary gland function BMC Oral Health 12 2012 29
12. S.M. Osailan, R. Pramanik, P. Shirlaw, G.B. Proctor, and S.J. Challacombe Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness Oral Surg Oral Med Oral Pathol Oral Radiol 114 5 2012 597 603
13. S. Pai, E.M. Ghezzi, and J.A. Ship Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 3 2001 311 316
14. E.W. Gerdin, S. Einarson, M. Jonsson, K. Aronsson, and I. Johansson Impact of dry mouth conditions on oral health-related quality of life in older people Gerodontology 22 4 2005 219 226
15. P. Dirix, S. Nuyts, V. Vander Poorten, P. Delaere, and W. Van den Bogaert The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer Support Care Cancer 16 2 2008 171 179
16. A. Tincani, L. Andreoli, I. Cavazzana, A. Doria, M. Favero, and M.G. Fenini Novel aspects of Sjögren's syndrome in 2012 BMC Med 11 2013 93
17. P. López-Jornet, F. Camacho-Alonso, and A. Bermejo-Fenoll A simple test for salivary gland hypofunction using Oral Schirmer's test J Oral Pathol Med 35 4 2006 244 248
18. P. Varela-Centelles, M. Sanchez-Sanchez, and J. Seoane Lip biopsy for the diagnosis of Sjögren's syndrome: beware of the punch Int J Oral Maxillofac Surg 43 1 2014 127 130
19. M. Maragou, E. Vaikousis, A. Ntre, N. Koronis, P. Georgiou, and E. Hatzidimitriou Tear and saliva ferning tests in Sjögren's syndrome (SS) Clin Rheumatol 15 2 1996 125 132
20. Y. Fujimaki, K. Tsunoda, S.I. Ishimoto, K. Okada, M. Kinoshita, and H. Igaki Non-invasive objective evaluation of radiotherapy-induced dry mouth J Oral Pathol Med 43 2 2014 97 102
21. J.J. Thorn, J.U. Prause, and P. Oxholm Sialochemistry in Sjögren's syndrome: a review J Oral Pathol Med 18 8 1989 457 468
22. W.W. Kalk, A. Vissink, F.K. Spijkervet, H. Bootsma, C.G. Kallenberg, and A.V. Nieuw Amerongen Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome Ann Rheum Dis 60 12 2001 1110 1116
23. A. Almståhl, M. Wikström, and J. Groenink Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins Oral Microbiol Immunol 16 6 2001 345 352
24. C.A. Murdoch-Kinch Salivary gland imaging J Calif Dent Assoc 39 9 2011 649 654
25. Q. Zou, J. Jiao, M.H. Zou, J.H. Xu, Y.F. Pan, and J.N. Chen Semi-quantitative evaluation of salivary gland function in Sjögren's syndrome using salivary gland scintigraphy Clin Rheumatol 31 12 2012 1699 1705
26. S. Klutmann, K.H. Bohuslavizki, S. Kröger, C. Bleckmann, W. Brenner, and J. Mester Quantitative salivary gland scintigraphy J Nucl Med Technol 27 1 1999 20 26
27. J. Sánchez-Guerrero, E. Aguirre-García, M.R. Pérez-Dosal, A. Kraus, M.H. Cardiel, and A.E. Soto-Rojas The wafer test: a semi-quantitative test to screen for xerostomia Rheumatology 41 4 2002 381 389
28. H. Kato, M. Kanematsu, M. Toida, T. Kawaguchi, T. Shibata, and K. Kajita Salivary gland function evaluated by diffusion-weighted MR imaging with gustatory stimulation: preliminary results J Magn Reson Imaging 34 4 2011 904 909
29. C.J. Burke, R.H. Thomas, and D. Howlett Imaging the major salivary glands Br J Oral Maxillofac Surg 49 4 2011 261 269
30. M.A. Orlandi, V. Pistorio, and P.A. Guerra Ultrasound in sialadenitis J Ultrasound 16 1 2013 3 9
31. J.J. Napeñas, M.T. Brennan, and P.C. Fox Diagnosis and treatment of xerostomia (dry mouth) Odontology 97 2 2009 76 83
32. L.M. Sreebny, and S.S. Schwartz A reference guide to drugs and dry mouth - 2nd edition Gerodontology 14 1 1997 33 47
33. N.N. Kumar, M.G. Panchaksharappa, and R.G. Annigeri Modified schirmer test - a screening tool for xerostomia among subjects on antidepressants Arch Oral Biol 59 8 2014 829 834
34. R. Uher, A. Farmer, N. Henigsberg, M. Rietschel, O. Mors, and W. Maier Adverse reactions to antidepressants Br J Psychiatry 195 3 2009 202 210
35. V. de Almeida Pdel, A.M. Grégio, J.A. Brancher, S.A. Ignácio, M.A. Machado, and A.A. de Lima Effects of antidepressants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 1 2008 58 65
36. J.S. Kennedy, D. Jeste, C.J. Kaiser, S. Golshan, G.A. Maguire, and G. Tollefson Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial Int J Geriatr Psychiatry 18 11 2003 1013 1020
37. M. Tardy, M. Huhn, R.R. Engel, and S. Leucht Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia Cochrane Database Syst Rev 8 2014 CD009230
38. M. Proulx, F.P. de Courval, M.A. Wiseman, and M. Panisset Salivary production in Parkinson's disease Mov Disord 20 2 2005 204 207
39. S. Elad, S. Heisler, and M. Shalit Saliva secretion in patients with allergic rhinitis Int Arch Allergy Immunol 141 3 2006 276 280
40. T. Yokoyama, T. Koide, R. Hara, K. Fukumoto, Y. Miyaji, and A. Nagai Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study Urol Int 90 2 2013 161 167
41. O. Yamaguchi, E. Marui, H. Kakizaki, N. Itoh, T. Yokota, and H. Okada Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder BJU Int 100 3 2007 579 587
42. R. Casaburi, D.D. Briggs Jr., J.F. Donohue, C.W. Serby, S.S. Menjoge, and T.J. Witek Jr. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial Chest 118 5 2000 1294 1302
43. P.W. Nance, J. Bugaresti, K. Shellenberger, W. Sheremata, and A. Martinez-Arizala Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury Neurology 44 11 Suppl. 9 1994 S44 S51
44. B. Götrick, D. Giglio, and G. Tobin Effects of amphetamine on salivary secretion Eur J Oral Sci 117 3 2009 218 223
45. P. Chervinsky, A. Nayak, A. Rooklin, and M. Danzig Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis Allergy Asthma Proc 26 5 2005 391 396
46. K. Najafizadeh, H. Sohrab Pour, M. Ghadyanee, M. Shiehmorteza, M. Jamali, and S. Majdzadeh A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma Emerg Med J 24 5 2007 317 321
47. T.M. Oakes, C. Katona, P. Liu, M. Robinson, J. Raskin, and J.H. Greist Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies Int Clin Psychopharmacol 28 1 2013 1 11
48. K.M. Habbab, D.R. Moles, and S.R. Porter Potential oral manifestations of cardiovascular drugs Oral Dis 16 8 2010 769 773
49. V. Nonzee, S. Manopatanakul, and S.O. Khovidhunkit Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications J Med Assoc Thai 95 1 2012 96 104
50. A.C. Takakura, T.S. Moreira, D.S. Colombari, L.A. De Luca Jr., and J.V. Menani Activation of alpha(2)-adrenoceptors in the lateral hypothalamus reduces pilocarpine-induced salivation in rats Neurosci Lett 450 3 2009 225 228
51. T. Hattori, and P.L. Wang Calcium antagonists cause dry mouth by inhibiting resting saliva secretion Life Sci 81 8 2007 683 690
52. C. Scully Drug effects on salivary glands: dry mouth Oral Dis 9 4 2003 165 176
53. Y. Nagao, K. Hashimoto, and M. Sata Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases BMC Gastroenterol 12 2012 155
54. A. Aghemo, M.G. Rumi, S. Monico, M. Banderali, A. Russo, and F. Ottaviani Ribavirin impairs salivary gland function during combination treatment with pegylated interferon alfa-2a in hepatitis C patients Hepat Mon 11 11 2011 918 924
55. S.B. Jensen, H.T. Mouridsen, J. Reibel, N. Brünner, and B. Nauntofte Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction Oral Oncol 44 2 2008 162 173
56. P.B. Lockhart, and S.T. Sonis Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study J Dermatol Surg Oncol 7 12 1981 1019 1025
57. M. Navazesh, R. Mulligan, R. Karim, W.J. Mack, S. Ram, and H. Seirawan Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS) Oral Dis 15 1 2009 52 60
58. M. Navazesh, R. Mulligan, Y. Barrón, M. Redford, D. Greenspan, and M. Alves A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 6 2003 693 698
59. I.D. White, P.J. Hoskin, G.W. Hanks, and J.M. Bliss Morphine and dryness of the mouth BMJ 298 6682 1989 1222 1223
60. J. Todd, E. Rees, B. Gwilliam, and A. Davies An assessment of the efficacy and tolerability of a 'double dose' of normal-release morphine sulphate at bedtime Palliat Med 16 6 2002 507 512
61. H. Looström, S. Akerman, D. Ericson, G. Tobin, and B. Götrick Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA Arch Oral Biol 56 4 2011 395 400
62. M.V. Zaclikevis, A.C. D'Agulham, L.E. Bertassoni, M.A. Machado, A.A. de Lima, and A.M. Grégio Effects of benzodiazepine and pilocarpine on rat parotid glands: histomorphometric and sialometric study Med Chem 5 1 2009 74 78
63. P. Winner, D. Lewis, W.H. Visser, K. Jiang, S. Ahrens, and J.K. Evans Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study Headache 42 1 2002 49 55
64. S. Silberstein, S. Tepper, J. Brandes, M. Diamond, J. Goldstein, and P. Winner Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine Neurology 62 9 2004 1552 1557
65. I. Ieiri, K. Hirata, S. Higuchi, K. Kojima, M. Ikeda, and H. Yamada Pharmacoepidemiological study on adverse reactions of antiepileptic drugs Chem Pharm Bull (Tokyo) 40 5 1992 1280 1288
66. T. Fahlén, H.L. Nilsson, K. Borg, M. Humble, and U. Pauli Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study Acta Psychiatr Scand 92 5 1995 351 358
67. A. Tanghe, S. Geerts, J. Van Dorpe, B. Brichard, J. Bruhwyler, and J. Géczy Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression Acta Psychiatr Scand 96 2 1997 134 141
68. P.M. Bet, J.G. Hugtenburg, B.W. Penninx, and W.J. Hoogendijk Side effects of antidepressants during long-term use in a naturalistic setting Eur Neuropsychopharmacol 23 11 2013 1443 1451
69. B. Guy-Grand, M. Apfelbaum, G. Crepaldi, A. Gries, P. Lefebvre, and P. Turner International trial of long-term dexfenfluramine in obesity Lancet 2 8672 1989 1142 1145
70. J.G. Kang, C.Y. Park, J.H. Kang, Y.W. Park, and S.W. Park Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity Diabetes Obes Metab 12 10 2010 876 882
71. C.H. Smith, B. Boland, Y. Daureeawoo, E. Donaldson, K. Small, and J. Tuomainen Effect of aging on stimulated salivary flow in adults J Am Geriatr Soc 61 5 2013 805 808
72. W. Pedersen, M. Schubert, K. Izutsu, T. Mersai, and E. Truelove Age-dependent decreases in human submandibular gland flow rates as measured under resting and post-stimulation conditions J Dent Res 64 5 1985 822 825
73. R.S. Percival, S.J. Challacombe, and P.D. Marsh Flow rates of resting whole and stimulated parotid saliva in relation to age and gender J Dent Res 73 8 1994 1416 1420
74. C.A. Tylenda, J.A. Ship, P.C. Fox, and B.J. Baum Evaluation of submandibular salivary flow rate in different age groups J Dent Res 67 9 1988 1225 1228
75. E.M. Ghezzi, and J.A. Ship Aging and secretory reserve capacity of major salivary glands J Dent Res 82 10 2003 844 848
76. D. Locker Subjective reports of oral dryness in an older adult population Community Dent Oral Epidemiol 21 3 1993 165 168
77. S.R. Shetty, S. Bhowmick, R. Castelino, and S. Babu Drug induced xerostomia in elderly individuals: an institutional study Contemp Clin Dent 3 2 2012 173 175
78. B.J. Baum, E.E. Kousvelari, and F.G. Oppenheim Exocrine protein secretion from human parotid glands during aging: stable release of the acidic proline-rich proteins J Gerontol 37 4 1982 392 395
79. M.S. Finkelstein, M. Tanner, and M.L. Freedman Salivary and serum IgA levels in a geriatric outpatient population J Clin Immunol 4 2 1984 85 91
80. C.K. Yeh, D.A. Johnson, and M.W. Dodds Impact of aging on human salivary gland function: a community-based study Aging (Milano) 10 5 1998 421 428
81. I. von Bültzingslöwen, T.P. Sollecito, P.C. Fox, T. Daniels, R. Jonsson, and P.B. Lockhart Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 2007 S57.e1-15
82. I. Al-Hashimi The management of Sjögren's syndrome in dental practice J Am Dent Assoc 132 10 2001 1409 1417
83. G. Stojan, A.N. Baer, and S.K. Danoff Pulmonary manifestations of Sjögren's syndrome Curr Allergy Asthma Rep 13 4 2013 354 360
84. I. Berglová, J. Krejsek, M. Kolácková, and R. Slezák B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome Acta Medica 54 2 2011 51 57
85. S.C. Shiboski, C.H. Shiboski, L. Criswell, A. Baer, S. Challacombe, and H. Lanfranchi American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort Arthritis Care Res (Hoboken) 64 4 2012 475 487
86. A. Aliko, R. Ciancaglini, A. Alushi, and A. Tafaj Sicca symptoms, and lacrimal and salivary flow in Albanian patients with rheumatoid arthritis J Oral Pathol Med 39 8 2010 651 656
87. L.M. Helenius, J.H. Meurman, I. Helenius, K. Kari, J. Hietanen, and R. Suuronen Oral and salivary parameters in patients with rheumatic diseases Acta Odontol Scand 63 5 2005 284 293
88. J.L. Jensen, H.O. Bergem, I.M. Gilboe, G. Husby, and T. Axéll Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus J Oral Pathol Med 28 7 1999 317 322
89. H. Ben-Aryeh, N. Gordon, R. Szargel, E. Toubi, and D. Laufer Whole saliva in systemic lupus erythematosus patients Oral Surg Oral Med Oral Pathol 75 6 1993 696 699
90. A.G. Walton, R.R. Welbury, H.E. Foster, W.G. Wright, and J.M. Thomason Sialochemistry in juvenile idiopathic arthritis Oral Dis 8 6 2002 287 290
91. F.W. Mang, P. Michieletti, K. O'Rourke, K. Cauch-Dudek, N. Diamant, and A. Bookman Primary biliary cirrhosis, sicca complex, and dysphagia Dysphagia 12 3 1997 167 170
92. K. Ivanovski, V. Naumovski, M. Kostadinova, S. Pesevska, K. Drijanska, and V. Filipce Xerostomia and salivary levels of glucose and urea in patients with diabetes Prilozi 33 2 2012 219 229
93. I.M. Busato, S.A. Ignácio, J.A. Brancher, S.T. Moysés, and L.R. Azevedo-Alanis Impact of clinical status and salivary conditions on xerostomia and oral health-related quality of life of adolescents with type 1 diabetes mellitus Community Dent Oral Epidemiol 40 1 2012 62 69
94. S.A. Al-Maweri, N.M. Ismail, A.R. Ismail, and A. Al-Ghashm Prevalence of oral mucosal lesions in patients with type 2 diabetes attending Hospital Universiti Sains Malaysia Malays J Med Sci 20 4 2013 39 46
95. L.M. Sreebny, A. Yu, A. Green, and A. Valdini Xerostomia in diabetes mellitus Diabetes Care 15 7 1992 900 904
96. S.P. Changlai, W.K. Chen, C. Chung, and S.M. Chiou Objective evidence of decreased salivary function in patients with autoimmune thyroiditis (chronic thyroiditis, Hashimoto's thyroiditis) Nucl Med Commun 23 10 2002 1029 1033
97. D. Muralidharan, N. Fareed, P.V. Pradeep, S. Margabandhu, K. Ramalingam, and B.V. Ajith Kumar Qualitative and quantitative changes in saliva among patients with thyroid dysfunction prior to and following the treatment of the dysfunction Oral Surg Oral Med Oral Pathol Oral Radiol 115 5 2013 617 623
98. M. Bergdahl, J. Bergdahl, and I. Johansson Depressive symptoms in individuals with idiopathic subjective dry mouth J Oral Pathol Med 26 10 1997 448 450
99. S.S. Anttila, M.L. Knuuttila, and T.K. Sakki Depressive symptoms as an underlying factor of the sensation of dry mouth Psychosom Med 60 2 1998 215 218
100. H. Bagheri, C. Damase-Michel, M. Lapeyre-Mestre, S. Cismondo, D. O'Connell, and J.M. Senard A study of salivary secretion in Parkinson's disease Clin Neuropharmacol 22 4 1999 213 215
101. R. Saeves, H. Nordgarden, K. Storhaug, L. Sandvik, and I. Espelid Salivary flow rate and oral findings in Prader-Willi syndrome: a case-control study Int J Paediatr Dent 22 1 2012 27 36
102. I. Johansson, M. Ryberg, L. Steen, and L. Wigren Salivary hypofunction in patients with familial amyloidotic polyneuropathy Oral Surg Oral Med Oral Pathol 74 6 1992 742 748
103. M.A. Sánchez-Pablo, V. González-García, and A. del Castillo-Rueda Study of total stimulated saliva flow and hyperpigmentation in the oral mucosa of patients diagnosed with hereditary hemochromatosis. Series of 25 cases Med Oral Patol Oral Cir Bucal 17 1 2012 e45 e49
104. B. Dayan, D. Elstein, A. Zimran, and G. Nesher Decreased salivary output in patients with Gaucher disease QJM 96 1 2003 53 56
105. W.L. Siqueira, M.F. Siqueira, Z. Mustacchi, E. de Oliveira, and J. Nicolau Salivary parameters in infants aged 12 to 60 months with Down syndrome Spec Care Dentist 27 5 2007 202 205
106. C. Areias, B. Sampaio-Maia, M.L. Pereira, A. Azevedo, P. Melo, and C. Andrade Reduced salivary flow and colonization by mutans streptococci in children with Down syndrome Clinics (Sao Paulo) 67 9 2012 1007 1011
107. M.J. Gelbier, and G.B. Winter Absence of salivary glands in children with rampant dental caries: report of seven cases Int J Paediatr Dent 5 4 1995 253 257
108. M. Yildirim, E. Yorgancilar, R. Gun, and I. Topcu Ectodermal dysplasia: otolaryngologic evaluation of 23 cases Ear Nose Throat J 91 2 2012 E28 E33
109. B. Bergendal, A. McAllister, and C. Stecksén-Blicks Orofacial dysfunction in ectodermal dysplasias measured using the Nordic Orofacial Test-Screening protocol Acta Odontol Scand 67 6 2009 377 381
110. T. Lundgren, S. Twetman, I. Johansson, C.G. Crossner, and D. Birkhed Saliva composition in children and young adults with Papillon-Lefèvre syndrome J Clin Periodontol 23 12 1996 1068 1072
111. M.B. Fortes, B.C. Diment, U. Di Felice, and N.P. Walsh Dehydration decreases saliva antimicrobial proteins important for mucosal immunity Appl Physiol Nutr Metab 37 October (5) 2012 850 859
112. J.A. Ship, and D.J. Fischer The relationship between dehydration and parotid salivary gland function in young and older healthy adults J Gerontol A Biol Sci Med Sci 52 5 1997 M310 M319
113. M. Keles, B. Seven, E. Varoglu, A. Uyanik, K. Cayir, and A. Kursad Ayan Salivary gland function in continuous ambulatory peritoneal dialysis patients by 99mTc-pertechnetate scintigraphy Hell J Nucl Med 13 1 2010 26 29
114. S. Patil, S. Khaandelwal, B. Doni, F. Rahuman, and S. Kaswan Oral manifestations in chronic renal failure patients attending two hospitals in North Karnataka, India Oral Health Dent Manag 11 3 2012 100 106
115. M. Postorino, C. Catalano, C. Martorano, S. Cutrupi, C. Marino, and P. Cozzupoli Salivary and lacrimal secretion is reduced in patients with ESRD Am J Kidney Dis 42 4 2003 722 728
116. A.W. Dynesen, A. Bardow, B. Petersson, L.R. Nielsen, and B. Nauntofte Salivary changes and dental erosion in bulimia nervosa Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 5 2008 696 707
117. S.K. Dutta, M. Orestes, S. Vengulekur, and P. Kwo Ethanol and human saliva: effect of chronic alcoholism on flow rate, composition, and epidermal growth factor Am J Gastroenterol 87 3 1992 350 354
118. Y.C. Wu, Y.P. Wang, J.Y. Chang, S.J. Cheng, H.M. Chen, and A. Sun Oral manifestations and blood profile in patients with iron deficiency anemia J Formos Med Assoc 113 2 2014 83 87
119. A. Jainkittivong, A.L. Lin, D.A. Johnson, R.P. Langlais, and C.K. Yeh Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients Oral Dis 15 3 2009 229 234
120. S.R. Porter, C. Scully, and A.M. Hegarty An update of the etiology and management of xerostomia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 1 2004 28 46
121. L. Henderson, M. Muir, P.R. Mills, E. Spence, R. Fox, and E.A. McCruden Oral health of patients with hepatitis C virus infection: a pilot study Oral Dis 7 5 2001 271 275
122. B.R. Blazar, W.J. Murphy, and M. Abedi Advances in graft-versus-host disease biology and therapy Nat Rev Immunol 12 6 2012 443 458
123. R.M. Nagler, Y. Sherman, and A. Nagler Histopathological study of the human submandibular gland in graft versus host disease J Clin Pathol 52 5 1999 395 397
124. M.M. Imanguli, J.C. Atkinson, S.A. Mitchell, D.N. Avila, R.J. Bishop, and E.W. Cowen Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation Biol Blood Marrow Transplant 16 10 2010 1362 1369
125. M.J. Mansour, C. He, S.T. Al-Farra, S.A. Khuder, J.M. Wright, and H.P. Kessler Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation J Oral Pathol Med 42 8 2013 594 599
126. A.A. Drosos, P.V. Voulgari, D.N. Psychos, N. Tsifetaki, and M. Bai Sicca syndrome in patients with sarcoidosis Rheumatol Int 18 5-6 1999 177 180
127. T. Kamisawa, Y. Tu, N. Egawa, N. Sakaki, S. Inokuma, and N. Kamata Salivary gland involvement in chronic pancreatitis of various etiologies Am J Gastroenterol 98 2 2003 323 326
128. N.L. Rhodus, J. Fricton, P. Carlson, and R. Messner Oral symptoms associated with fibromyalgia syndrome J Rheumatol 30 8 2003 1841 1845
129. K.C. Leung, A.S. McMillan, W.K. Leung, M.C. Wong, C.S. Lau, and T.M. Mok Oral health condition and saliva flow in southern Chinese with Sjögren's syndrome Int Dent J 54 3 2004 159 165
130. B.E. Miller, O. Deutsch, M. Redlich, Y.T. Konttinen, R. Benoliel, and B. Zaks Sialochemistry and cortisol levels in patients with Sjogren's syndrome Oral Dis 18 3 2012 255 259
131. A.L. Lin, D.A. Johnson, K.T. Stephan, and C.K. Yeh Alteration in salivary function in early HIV infection J Dent Res 82 9 2003 719 724
132. V.N. Okoje, A.E. Obiechina, and Y.A. Aken'Ova Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan Afr J Med Med Sci 35 1 2006 97 101
133. W. Nittayananta, N. Chanowanna, S. Jealae, B. Nauntofte, and K. Stoltze Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era J Oral Pathol Med 39 1 2010 28 34
134. H.S. Brand, C.P. Bots, and J.E. Raber-Durlacher Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation Br Dent J 207 9 2009 E17
135. A. Eisbruch, H.M. Kim, J.E. Terrell, L.H. Marsh, L.A. Dawson, and J.A. Ship Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 3 2001 695 704
136. S.C. Lin, Y.M. Jen, Y.C. Chang, and C.C. Lin Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire J Pain Symptom Manage 36 2 2008 141 148
137. P. Dirix, F. De Keyzer, V. Vandecaveye, S. Stroobants, R. Hermans, and S. Nuyts Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy Int J Radiat Oncol Biol Phys 71 5 2008 1365 1371
138. J.G. Mira, W.B. Wescott, E.N. Starcke, and I.L. Shannon Some factors influencing salivary function when treating with radiotherapy Int J Radiat Oncol Biol Phys 7 4 1981 535 541
139. C. de Barros Pontes, A.C. Polizello, and A.C. Spadaro Clinical and biochemical evaluation of the saliva of patients with xerostomia induced by radiotherapy Braz Oral Res 18 1 2004 69 74
140. A. Almståhl, and M. Wikström Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins Arch Oral Biol 48 5 2003 337 344
141. C.A. Murdoch-Kinch, H.M. Kim, K.A. Vineberg, J.A. Ship, and A. Eisbruch Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy Int J Radiat Oncol Biol Phys 72 2 2008 373 382
142. F.R. Burlage, R.P. Coppes, H. Meertens, M.A. Stokman, and A. Vissink Parotid and submandibular/sublingual salivary flow during high dose radiotherapy Radiother Oncol 61 3 2001 271 274
143. A.W. Konings, R.P. Coppes, and A. Vissink On the mechanism of salivary gland radiosensitivity Int J Radiat Oncol Biol Phys 62 4 2005 1187 1194
144. O. Grundmann, G.C. Mitchell, and K.H. Limesand Sensitivity of salivary glands to radiation: from animal models to therapies J Dent Res 88 10 2009 894 903
145. J. Yarnold, and M.C. Brotons Pathogenetic mechanisms in radiation fibrosis Radiother Oncol 97 1 2010 149 161
146. H. Gustafsson, Y. Aalto, L. Franzén, L.E. Thornell, and R. Henriksson Effects of fractionated irradiation on the cytoskeleton and basal lamina in parotid glands - an immunohistochemical study Acta Oncol 37 1 1998 33 40
147. S.G. Hakim, Jacobsen HCh, D. Hermes, H. Kosmehl, I. Lauer, and R. Nadrowitz Early immunohistochemical and functional markers indicating radiation damage of the parotid gland Clin Oral Investig 8 1 2004 30 35
148. J.L. Avila, O. Grundmann, R. Burd, and K.H. Limesand Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis Int J Radiat Oncol Biol Phys 73 2 2009 523 539
149. B. Cannon, D.L. Schwartz, and L. Dong Metabolic imaging biomarkers of postradiotherapy xerostomia Int J Radiat Oncol Biol Phys 83 5 2012 1609 1616
150. J.C. Atkinson, M. Grisius, and W. Massey Salivary hypofunction and xerostomia: diagnosis and treatment Dent Clin North Am 49 2 2005 309 326
151. C.A. De Souza, G. Santini, G. Marino, S. Nati, A.M. Congiu, and A.C. Vigorito Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study Braz J Med Biol Res 33 7 2000 791 798
152. A.D. Sasse, L.G. Clark, E.C. Sasse, and O.A. Clark Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis Int J Radiat Oncol Biol Phys 64 3 2006 784 791
153. T.H. Wasserman, D.M. Brizel, M. Henke, A. Monnier, F. Eschwege, and R. Sauer Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial Int J Radiat Oncol Biol Phys 63 4 2005 985 990
154. A.P. Cotrim, F. Hyodo, K. Matsumoto, A.L. Sowers, J.A. Cook, and B.J. Baum Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging Clin Cancer Res 13 16 2007 4928 4933
155. I.M. Lombaert, J.F. Brunsting, P.K. Wierenga, H.H. Kampinga, G. de Haan, and R.P. Coppes Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool Stem Cells 26 10 2008 2595 2601
156. K.H. Limesand, S. Said, and S.M. Anderson Suppression of radiation-induced salivary gland dysfunction by IGF-1 PLoS ONE 4 3 2009 e4663
157. C. Zheng, A.P. Cotrim, A. Rowzee, W. Swaim, A. Sowers, and J.B. Mitchell Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands Clin Cancer Res 17 9 2011 2842 2851
158. A. Teymoortash, F. Müller, J. Juricko, M. Bieker, R. Mandic, and D. Librizzi Botulinum toxin prevents radiotherapy-induced salivary gland damage Oral Oncol 45 8 2009 737 739
159. X.K. Liu, Y. Su, N. Jha, M.H. Hong, H.Q. Mai, and W. Fan Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes Head Neck 33 3 2011 389 395
160. B.J. Baum, C. Zheng, A.P. Cotrim, L. McCullagh, C.M. Goldsmith, and J.S. Brahim Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction Handb Exp Pharmacol 190 2009 403 418
161. C. Delporte, B.C. O'Connell, X. He, H.E. Lancaster, A.C. O'Connell, and P. Agre Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands Proc Natl Acad Sci U S A 94 7 1997 3268 3273
162. M.W. Epperly, M. Carpenter, A. Agarwal, P. Mitra, S. Nie, and J.S. Greenberger Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis In Vivo 18 4 2004 401 410
163. S. Palaniyandi, Y. Odaka, W. Green, F. Abreo, G. Caldito, and A. De Benedetti Adenoviral delivery of tousled kinase for the protection of salivary glands against ionizing radiation damage Gene Ther 18 3 2011 275 282
164. G.F. Ferraccioli, F. Salaffi, S. De Vita, L. Casatta, C. Avellini, and M. Carotti Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine Clin Exp Rheumatol 14 4 1996 367 371
165. J.A. Ship, P.C. Fox, J.E. Michalek, M.J. Cummins, and A.B. Richards Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial J Interferon Cytokine Res 19 8 1999 943 951
166. M.J. Cummins, A. Papas, G.M. Kammer, and P.C. Fox Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results Arthritis Rheum 49 4 2003 585 593
167. J. Pijpe, J.M. Meijer, H. Bootsma, J.E. van der Wal, F.K. Spijkervet, and C.G. Kallenberg Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome Arthritis Rheum 60 11 2009 3251 3256
168. A. Vissink, J.B. Mitchell, B.J. Baum, K.H. Limesand, S.B. Jensen, and P.C. Fox Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers Int J Radiat Oncol Biol Phys 78 4 2010 983 991
169. S. Hahnel, M. Behr, G. Handel, and R. Bürgers Saliva substitutes for the treatment of radiation-induced xerostomia - a review Support Care Cancer 17 11 2009 1143 1331
170. A. Vissink, E.J. s-Gravenmade, A.K. Panders, A. Vermey, J.K. Petersen, and L.L. Visch A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes Int J Oral Surg 12 4 1983 232 238
171. G. Regelink, A. Vissink, H. Reintsema, and J.M. Nauta Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia Quintessence Int 29 6 1998 383 388
172. F. Dost, and C.S. Farah Stimulating the discussion on saliva substitutes: a clinical perspective Aust Dent J 58 1 2013 11 17
173. A.Y. Kam, A.S. McMillan, E.H. Pow, K.C. Leung, and H.W. Luk A preliminary report on patient acceptance of a novel intra-oral lubricating device for the management of radiotherapy-related xerostomia Clin Oral Investig 9 3 2005 148 153
174. J. Tsibouklis, A.M. Middleton, N. Patel, and J. Pratten Toward mucoadhesive hydrogel formulations for the management of xerostomia: the physicochemical, biological, and pharmacological considerations J Biomed Mater Res A 101 11 2013 3327 3338
175. A.S. McMillan, C.S. Tsang, M.C. Wong, and A.Y. Kam Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia Oral Oncol 42 8 2006 842 848
176. L.J. Radvansky, M.B. Pace, and A. Siddiqui Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia Am J Health Syst Pharm 70 12 2013 1025 1032
177. A.V. Nieuw Amerongen, and E.C. Veerman Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies Support Care Cancer 11 4 2003 226 231
178. J.T. Johnson, G.A. Ferretti, W.J. Nethery, I.H. Valdez, P.C. Fox, and D. Ng Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer N Engl J Med 329 6 1993 390 395
179. J.B. Epstein, and M.M. Schubert Synergistic effect of sialagogues in management of xerostomia after radiation therapy Oral Surg Oral Med Oral Pathol 64 2 1987 179 182
180. T. Hamada, T. Nakane, T. Kimura, K. Arisawa, K. Yoneda, and T. Yamamoto Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial Am J Med Sci 318 3 1999 146 151
181. M.S. Chambers, M. Posner, C.U. Jones, M.A. Biel, K.M. Hodge, and R. Vitti Cevimeline for the treatment of postirradiation xerostomia in patients with head and eck cancer Int J Radiat Oncol Biol Phys 68 4 2007 1102 1109
182. B.C. Jham, I.V. Teixeira, C.G. Aboud, A.L. Carvalho, M. Coelho, and A.R. Freire A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer Oral Oncol 43 2 2007 137 142
183. J.M. Nanni, K.H. Nguyen, C.E. Alford, C.P. Robinson, C.M. Stewart, and N. Maeda Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse Clin Exp Rheumatol 15 5 1997 515 521
184. K. Adachi, M. Ono, A. Kawamura, M. Yuki, H. Fujishiro, and Y. Kinoshita Nizatidine and cisapride enhance salivary secretion in humans Aliment Pharmacol Ther 16 2 2002 297 301
185. T. Kasama, F. Shiozawa, T. Isozaki, M. Matsunawa, K. Wakabayashi, and T. Odai Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome Mod Rheumatol 18 5 2008 455 459
186. C. Van Loveren Sugar alcohols: what is the evidence for caries-preventive and caries-therapeutic effects? Caries Res 38 3 2004 286 293
187. C.L. Kleinegger Dental management of xerostomia - opportunity, expertise, obligation J Calif Dent Assoc 35 6 2007 417 424
188. S. Fedele, A. Wolff, F. Strietzel, R.M. López, S.R. Porter, and Y.T. Konttinen Neuroelectrostimulation in treatment of hyposalivation and xerostomia in Sjögren's syndrome: a salivary pacemaker J Rheumatol 35 8 2008 1489 1494
189. F.P. Braga, N.N. Sugaya, S.K. Hirota, I. Weinfeld, M.H. Magalhães, and D.A. Migliari The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia Minerva Stomatol 57 7-8 2008 343 348
190. M.K. Garcia, J.S. Chiang, L. Cohen, M. Liu, J.L. Palmer, and D.I. Rosenthal Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study Head Neck 31 10 2009 1360 1368
191. K. Cankar, Z. Finderle, and J. Jan The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours Caries Res 45 2 2011 136 141
192. D.N. Teguh, P.C. Levendag, I. Noever, P. Voet, H. van der Est, and P. van Rooij Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer Int J Radiat Oncol Biol Phys 75 3 2009 711 716
193. I.M. Lombaert, J.F. Brunsting, P.K. Wierenga, H.H. Kampinga, G. de Haan, and R.P. Coppes Cytokine treatment improves parenchymal and vascular damage of salivary glands after irradiation Clin Cancer Res 14 23 2008 7741 7750
194. J. Feng, M. van der Zwaag, M.A. Stokman, R. van Os, and R.P. Coppes Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation Radiother Oncol 92 3 2009 466 471
195. S. Pringle, R. Van Os, and R.P. Coppes Concise review: adult salivary gland stem cells and a potential therapy for xerostomia Stem Cells 31 4 2013 613 619 REVISÃO
196. C.Y. Lin, F.H. Chang, C.Y. Chen, C.Y. Huang, F.C. Hu, and W.K. Huang Cell therapy for salivary gland regeneration J Dent Res 90 3 2011 341 346
197. Y. Sumita, Y. Liu, S. Khalili, O.M. Maria, D. Xia, and S. Key Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation Int J Biochem Cell Biol 43 1 2011 80 87
198. T. Kojima, S. Kanemaru, S. Hirano, I. Tateya, S. Ohno, and T. Nakamura Regeneration of radiation damaged salivary glands with adipose-derived stromal cells Laryngoscope 121 9 2011 1864 1869
199. J.Y. Lim, T. Yi, J.S. Choi, Y.H. Jang, S. Lee, and H.J. Kim Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage Oral Oncol 49 2 2013 136 143
200. Y. Yamamura, H. Yamada, T. Sakurai, F. Ide, H. Inoue, and T. Muramatsu Treatment of salivary gland hypofunction by transplantation with dental pulp cells Arch Oral Biol 58 8 2013 935 942